Background-Pathology studies on fatal cases of very late stent thrombosis have described incomplete neointimal coverage as common substrate, in some cases appearing at side-branch struts. Intravascular ultrasound studies have described the association between incomplete stent apposition (ISA) and stent thrombosis, but the mechanism explaining this association remains unclear. Whether the neointimal coverage of nonapposed side-branch and ISA struts is delayed with respect to well-apposed struts is unknown. Methods and Results-Optical coherence tomography studies from 178 stents implanted in 99 patients from 2 randomized trials were analyzed at 9 to 13 months of follow-up. The sample included 38 sirolimus-eluting, 33 biolimus-eluting, 57 everolimus-eluting, and 50 zotarolimus-eluting stents. Optical coherence tomography coverage of nonapposed side-branch and ISA struts was compared with well-apposed struts of the same stent by statistical pooled analysis with a random-effects model. A total of 34 120 struts were analyzed. The risk ratio of delayed coverage was 9.00 (95% confidence interval, 6.58 to 12.32) for nonapposed side-branch versus well-apposed struts, 9.10 (95% confidence interval, 7.34 to 11.28) for ISA versus well-apposed struts, and 1.73 (95% confidence interval, 1.34 to 2.23) for ISA versus nonapposed side-branch struts. Heterogeneity of the effect was observed in the comparison of ISA versus well-apposed struts (Hϭ1.27; I 2 ϭ38.40) but not in the other comparisons. Conclusions-Coverage of ISA and nonapposed side-branch struts is delayed with respect to well-apposed struts in drug-eluting stents, as assessed by optical coherence tomography. Clinical Trial Registration-http://www.clinicaltrials.gov. Unique identifier: NCT00389220, NCT00617084. 
T he reduction of restenosis rates achieved by drug-eluting stents (DES) 1 has been obscured somewhat by concerns about their safety and the incidence of late and very late stent thrombosis. [2] [3] [4] [5] Clinical Perspective on p 623
Pathology studies have described delayed neointimal healing 6 -10 with incomplete endothelialization of the struts 10 as the common morphological finding in fatal cases of late and very late stent thrombosis. Some of these autopsy studies found incomplete neointimal coverage and fibrin deposition in struts lying across the takeoff of side branches in bifurcations, also termed nonapposed side-branch struts, thus identifying nonapposed side-branch struts as potential triggers for late and very late stent thrombosis. 7, 9 However, clinical studies on bifurcation stenting techniques have not confirmed this hypothesis. Jailing side branches is a widespread practice, and there is no clinical evidence of an eventual association with higher thrombotic risk. 11 Moreover, some randomized trials failed to prove any clinical advantage of strategies pursuing the apposition of nonapposed side-branch struts compared with the simple stenting across strategy. 12 Intravascular ultrasound studies have described consistently the association between incomplete stent apposition (ISA) and late and very late stent thrombosis. 13, 14 However, the mechanism responsible for this association is still not clear. ISA may represent a handicap per se for proper endothelialization, but may be the consequence of a primary process causing both ISA and late and very late stent thrombosis, as in the case of delayed hypersensitivity resulting in an inflammatory response, aneurysmal dilatation of the vessel wall, late-acquired malapposition, and thrombosis. 8, 15, 16 The elucidation of the mechanism linking ISA and thrombosis is relevant for the interventional cardiologist because it determines the importance of the optimization of apposition: Spending time and resources in optimization only makes sense if ISA is the primary problem. A recent descriptive sequential optical coherence tomography (OCT) study found that two thirds of acutely malapposed struts were uncovered at 10-month follow-up, suggesting that neointimal coverage may be hampered in ISA struts, 17 but no comparative analysis between ISA and well-apposed struts for the risk of incomplete coverage was performed. Thus far, no OCT study has addressed the question of whether ISA or nonapposed side-branch struts pose a higher risk of incomplete coverage in DES, the latter having been excluded from the analysis in most of the studies published to date. 18 -21 The aim of this OCT study is to evaluate whether the coverage of ISA and nonapposed side-branch struts is delayed with respect to well-apposed struts of the same stent in DES. 
Methods

Study Sample
Data at follow-up from the OCT substudies of 2 different randomized trials were analyzed: the Limus Eluted From a Durable Versus E r odable Stent Coating (LEADERS) trial, 22, 23 comparing a biolimus-eluting stent with biodegradable polymer in abluminal coating (BioMatrix Flex, Biosensors International, Morges, Switzerland) versus a sirolimus-eluting stent with durable polymer (Cypher SELECT, Cordis, Miami Lakes, FL); and the RESOLUTE-All Comers trial, 24 comparing a zotarolimus-eluting stent with hydrophilic polymer coating (Resolute, Medtronic Inc, Santa Rosa, CA) versus an everolimus-eluting stent with fluoropolymer (Xience V, Abbott Vascular, Santa Clara, CA). The design and results of these trials have been published elsewhere. [22] [23] [24] Both trials followed an all-comers design, with minimal exclusion criteria. In LEADERS, the OCT follow-up was scheduled at 9 months, whereas in RESOLUTE-All Comers, it was at 13 months.
Optical Coherence Tomography Study and Analysis
OCT pullbacks were obtained at follow-up with M2, M3, or C7 systems (Lightlab Imaging, Westford, MA), according to the availability at the participating sites, with an occlusive or nonocclusive technique as appropriate. 25 Table 1 summarizes the technical specifications of each OCT system and optical catheters. Infusion of intracoronary nitroglycerin before the OCT pullback was strongly encouraged.
OCT pullbacks were analyzed offline in a core laboratory (Cardialysis BV, Rotterdam, Netherlands) by independent staff blinded to stent-type allocation and clinical and procedural characteristics of the patients, with the use of proprietary software (Lightlab Imaging). Cross sections at 1-mm intervals within the stented segment and 5-mm proximal and distal to the stent edges were analyzed. A metallic strut typically appears as a bright signal-intense structure with dorsal shadowing. Apposition was assessed strut by strut by measuring the distance between the strut marker and the lumen contour. The marker of each strut was placed at the endoluminal leading edge, in the midpoint of its long axis, and the distance was measured following a straight line connecting this marker with the center of gravity of the vessel. 26 Struts were classified as ISA if the distance between the strut marker and the lumen contour was larger than the specific strut thickness plus the axial resolution of OCT (14 m) . This resulted in ISA thresholds of Ͼ168 m for sirolimuseluting stents, Ͼ131 m for biolimus-eluting stents, Ͼ99 m for everolimus-eluting stents, 111 m for zotarolimus-eluting stents, Figure 2 . Examples of malapposed (incomplete stent apposition [ISA] ) and nonapposed side-branch (NASB) struts appearing covered (white arrows) and uncovered (red arrows) at follow-up.
and 95 m for the combination drug-coated balloon plus bare-metal stents. Struts located at the ostium of side branches, with no vessel wall behind, were labeled as nonapposed side-branch struts and excluded from the analysis of apposition.
Struts were classified as uncovered if any part of the strut was visibly exposed to the lumen or were classified as covered if a layer of tissue was visible over all of the reflecting surfaces. In covered struts, the thickness of coverage was measured from the marker of each visible strut to the endoluminal edge of the tissue coverage, following a straight line connecting the strut marker with the center of gravity of the vessel. 18 -21,23 Each strut was finally categorized according to apposition as well-apposed, ISA, or nonapposed side-branch strut and according to coverage as covered or uncovered (Figures 1 and 2 ).
Statistical Analysis
The risk ratio (RR) for noncoverage of ISA and nonapposed side-branch strut was calculated versus well-apposed struts by pooled analysis with the use of an inverse variance random-effects model, taking into account the between-cluster and within-cluster variability, with each stent used as an independent unit of clustering (see Methods in the online-only Data Supplement). For each comparison between apposition categories, stents with zero struts in any of the compared apposition categories (no exposition) or zero uncovered struts (no events) were considered to be not informative to evaluate the RR and were discarded for the analysis. A proportional continuity correction was applied to stents with zero uncovered struts (zero events) in only 1 of the compared apposition categories. 27 The RR at each individual stent and the pooled RR of the whole sample were graphically represented by mean of forest plots. Analysis of heterogeneity of the effect was performed with the Q, H, and I 2 parameters, with consideration of the presence of heterogeneity when the P value of the test was Յ0.1. Calculations were done with PASW 17.0 software (Chicago, IL) with the use of a specific macro (Domenech JM). 28 The RR for noncoverage of ISA versus nonapposed side-branch struts was calculated by the same method.
Results
A total of 104 patients (131 lesions, 184 stents) were included in this study. Insufficient quality of the OCT pullback, owing to incomplete blood removal, led to exclusion of 5 patients from the analysis: 4 with sirolimus-eluting stents and 1 with a biolimus-eluting stent. Ninety-nine patients (22 with sirolimus-eluting stents, 19 with biolimus-eluting stents, 28 with everolimus-eluting stents, 30 with zotarolimus-eluting stents), 125 lesions, 178 stents, 34 120 struts, and 3796 mm of stented vessel were finally analyzed ( Figure 3 and tables in the online-only Data Supplement). Tables 2 and 3 summarize the baseline clinical and procedural characteristics of the patients and angiographic characteristics of the lesions in the sample, respectively, grouped by type of stent. There were significant differences between the groups in average number of implanted stents, bifurcation stenting, or reference vessel diameter. Table 4 shows the OCT-derived areas and volumes in the stented regions, excluding stent overlaps, averaged per stent. The parameters measuring neointimal hyperplasia were significantly different between the DES subgroups. Sixty-five stents had Ն1 ISA strut (35.3%). In this subgroup, the average in-stent mean lumen area (8.01Ϯ2.78 mm 2 ) was in between the average mean lumen areas of the proximal and distal reference segments (8.61Ϯ2.80 and 6.90Ϯ2.59 mm 2 , respectively). In 9 cases (13.2% of the ISA stents, 4.9% of total), the mean in-stent lumen area (8.85Ϯ1.98 mm 2 ) was larger than the mean lumen areas in both the proximal and distal reference segments (7.32Ϯ2.25 and 7.27Ϯ3.04 mm 2 , respectively) but not significantly larger than in the whole ISA subgroup (Pϭ0.333) ( Figure 4 ). ISA volume was not significantly different between the aneurysmal and nonaneurysmal subgroups (1.85Ϯ1.58 versus 2.24Ϯ3.00 mm 3 ; Pϭ0.707), respectively. The total number of ISA struts was significantly lower for the aneurysmal pattern (3.44 versus 6.77; Pϭ0.024). Table 5 shows the total count of struts in each apposition category in the whole sample and the raw proportions of coverage without clustering by patient, lesion, or stent. We found that 94.9% of well-apposed struts are covered at follow-up versus only 78.1% of nonapposed side-branch struts and 27.4% of ISA struts.
Raw Proportions of Coverage in the Global Sample
Risk of Noncoverage at the Stent Level
Seventy-three stents (41.0%) had nonapposed side-branch struts; 64 (36.0%) had Ն1 ISA strut, and 127 (71.3%) were incompletely covered at follow-up. The presence of nonapposed side-branch struts was significantly associated with incomplete coverage of the stent: 63 stents (86.3%) with nonapposed side-branch struts were incompletely covered compared with 64 (61.0%) without nonapposed sidebranch struts (Pϭ0.008). Likewise, the presence of ISA was significantly associated with incomplete coverage of the stent: 62 stents (96.9%) with ISA were incompletely covered compared with 65 totally well-apposed stents (57.0%) (PϽ0.0001). 
Coverage of Nonapposed Side-Branch Versus Well-Apposed Struts
One hundred five DES had no nonapposed side-branch struts; 11 DES across side branches had all nonapposed side-branch and well-apposed struts completely covered. Sixty-two DES (13 083 struts) were suitable for the pooled comparison of the risk of noncoverage in nonapposed side-branch (nϭ216) versus well-apposed struts (nϭ12 867). Nonapposed sidebranch struts present a RR for noncoverage of 9.00 (95% confidence interval, 6.58 to 12.32) compared with wellapposed struts (Table 6 and Figure 5 ). There was no significant heterogeneity of the effect in any of the subgroups (HϽ1; I 2 ϭ0).
Coverage of Incomplete Stent Apposition Versus Well-Apposed Struts
One hundred thirteen DES had no ISA struts; 3 DES with malapposition had all ISA and well-apposed struts completely covered. Sixty-two DES (12 558 struts) were suitable for the pooled comparison of the risk of noncoverage in ISA (nϭ405) versus well-apposed struts (nϭ12 153). ISA struts present a RR for noncoverage of 9.10 (95% confidence interval, 7.34 to 11.28) compared with wellapposed struts (Table 6 and Figure 6 ). The magnitude of the effect varied substantially between the different types of DES, ranging from 5.43 in sirolimus-eluting stents to 12.36 in everolimus-eluting stents. There was considerable heterogeneity of the effect, even after stratification by type of stent.
Coverage of ISA Versus Nonapposed Side-Branch Struts
Thirty-three DES (335 struts) were suitable for the pooled comparison of the risk of noncoverage in ISA (nϭ211) versus nonapposed side-branch struts (nϭ124). ISA struts present a RR for noncoverage of 1.73 (95% confidence interval, 1.34 to 2.23) compared with nonapposed side-branch struts (Table 6 and Figure 7 ). There was no significant heterogeneity of the effect in any of the subgroups (HϽ1; I 2 ϭ0). 
Discussion
The main findings of this analysis are as follows: (1) Coverage of ISA and nonapposed side-branch struts is delayed with respect to that of well-apposed struts in DES, as assessed by OCT; and (2) coverage of ISA struts is delayed with respect to that of nonapposed side-branch struts in DES, as assessed by OCT. These results suggest that the neointimal coverage of nonapposed side-branch and ISA struts is delayed with respect to well-apposed struts in DES.
Implications for Nonapposed Side-Branch Struts
To the best of our knowledge, this is the first human in vivo study addressing the coverage of nonapposed side-branch struts. Most of the recently published OCT studies excluded nonapposed side-branch struts from the analysis 18 -21 because they were methodologically cumbersome and their meaning was not fully understood. Our results clarify the impact of nonapposed side-branch struts on the coverage of the stent and may explain the apparent discrepancy between pathological and clinical studies in this respect. Although some pathological studies on patients deceased by stent thrombosis found incomplete neointimal coverage in struts at side branches, 7,9 stenting across continued to be a widespread practice, often the compromise solution for many challenging cases, and late and very late stent thrombosis still remained a rare complication. 29 The Nordic trial did not find any significant difference in clinical outcomes between a simple strategy of stenting across and a complex 2-stent technique. 11, 30 The Nordic III trial compared specifically the strategy of stenting across (a nonapposed side branchgenerating technique) versus systematic final kissing balloon (a nonapposed side branch-reducing technique) and also failed to find any clinical advantage for any of the strategies. 12 The inherent selection bias of autopsy studies has been thought to explain the discrepancy between pathology and clinical data. Our findings may reconcile these apparently contradictory observations: Most nonapposed side-branch struts (78%) appear covered at followup, explaining the good results reported in clinical trials; however, the neointimal healing is primarily impaired in nonapposed side-branch struts, and therefore the findings in autopsies may reflect a rare but real problem, which is not properly addressed in trials that were underpowered to detect late and very late stent thrombosis. Therefore, although stenting across is becoming the default technique for bifurcation stenting, it may pose some disadvantage for complete neointimal coverage. 
Implications for Incomplete Stent Apposition Struts
Ozaki et al 17 reported a descriptive sequential OCT study in a sirolimus-eluting stent series, showing that 65% of acutely malapposed struts were uncovered at 6 months, in contrast with only 9% of the well-apposed struts. This observation suggests that neointimal coverage of ISA struts may be delayed with respect to well-apposed struts. Our study confirms the hypothesis generated by the report of Ozaki et al, comparing for the first time the risk of incomplete coverage at follow-up between the different apposition categories within the same stent and therefore comparing struts subjected to identical environmental conditions. This approach provides solid evidence about the effect of apposition on coverage, even though it analyzes only the outcome at follow-up. Although it is generally accepted that sequential studies provide more solid evidence about risk estimation, this statement is not totally accurate in the case of OCT because of the impossibility of tracking individual struts between 2 time points. Sequential OCT studies are based on assumptions and approximations that represent some degree of inaccuracy and bias. Analyzing OCT only at follow-up, we found a raw proportion of uncovered ISA struts (72.6%) in the DES group similar to that reported by Ozaki in sirolimuseluting stents. 17 Intravascular ultrasound studies have described the association between ISA and late and very late stent thrombosis, 13, 14 but the mechanism of this association remains unclear. The demonstration that ISA struts have a higher risk of noncoverage than well-apposed struts strongly suggests that the underlying mechanism explaining this association might be a deficient reendothelialization of ISA struts. This means that ISA is a risk factor for incomplete coverage in DES, and the effort to optimize apposition may be justified.
Inflammation is an alternative mechanism to explain the association between ISA and thrombosis described in firstgeneration DES. 8, 15 Vasculitis of the 3 arterial layers may cause weakening of the vessel wall and aneurysmal dilatation, resulting in late-acquired ISA. 31 Intravascular ultrasound studies have reported larger in-stent mean external elastic membrane area in cases of very late stent thrombosis than in control DES and also larger than in the corresponding proximal and distal reference segments. 15 In regard to the inflammatory mechanism, ISA would be the consequence of a common primary process causing both thrombosis and ISA, and therefore the optimization of acutely malapposed struts would make little sense. However, the inflammatory mechanism cannot explain our results. First, this analysis stems from an asymptomatic cohort of patients who have not suffered thrombotic events to date, in contrast to prior case-control designs. 13 Second, the analysis of lumen area in the stents with ISA does not fit well with the aneurysmal pattern described by intravascular ultrasound in the case of inflammatory stent thrombosis. 13 Finally, and most importantly, the deficient coverage in ISA is also observed in nonapposed side-branch struts, which become nonapposed side-branch struts at the moment of implantation and certainly not as the consequence of a late hypersensitivity reaction. A third theoretical mechanism to explain the association between ISA and stent thrombosis is confounding: A severely diseased coronary segment would be more prone to a suboptimal apposition result and more prone to suffer thrombotic events, resulting in a spurious association between ISA and thrombosis. In that case, ISA would be a marker of poor prognosis, unlikely to change by optimizing the apposition. Although this possibility cannot be strictly ruled out in our study, the parallelism with the coverage in nonapposed side-branch struts makes this mechanism unlikely to explain the results. When all of these factors are considered together, this study constitutes solid evidence that ISA is a primary risk factor for incomplete neointimal coverage, encouraging the procedural optimization of apposition to the greatest possible extent.
Nonapposed Side-Branch and Incomplete Stent Apposition Struts: Equivalent or Different?
Although both nonapposed side-branch and ISA struts share a higher risk of delayed coverage, they seem to present slightly different scenarios. Acute ISA is caused by a severely diseased vessel or other underlying condition precluding correct apposition. This scenario may be associated with irregular drug release due to contact of the struts with the necrotic core, 32 severely dysfunctional endothelium with hampered regeneration capabilities, or more severe structural deformations in the stent platform. These reasons may explain the heterogeneous effect observed in ISA struts. This heterogeneity is only partially explained by the type of stent and deserves further clarification in the future. Conversely, nonapposed side-branch struts are not in contact with plaque, necrotic core, or calcium. Presumably, they are enshrined in Figure 4 . Mean lumen areas by optical coherence tomography in the stented segment and in the proximal/distal reference segments. The top panel represents the mean areas (left) and individual areas (right) of the 73 stents with incomplete stent apposition (ISA). Only in 11 stents (bottom) was the mean in-stent lumen area larger than in both the proximal and distal reference segments, a typical pattern described in cases of stent thrombosis.
a less severely diseased segment of the vessel, and the stent has suffered less structural distortion at that level. Probably this constitutes a more benign and predictable scenario than the one described for ISA and may explain the homogeneous effect observed in nonapposed side-branch struts and the higher risk of noncoverage observed in ISA versus nonapposed side-branch struts.
Pooled Analysis as a Model for Inference at the Strut Level
Research in the field of OCT must face a cumbersome methodological challenge: The level of measurement (the strut) is different from the level of analysis (the patient or, exceptionally, the lesion/stent). The clustering of the units of measurement at different levels (patient, lesion, stent) makes the probability of the outcome not independent, thus violating one of the conditions of using conventional statistics. A mathematical model that takes into account between-cluster and within-cluster variability is required. Bayesian hierarchical 23 or multilevel regression models have therefore been proposed. In this study, we use a pooled analysis for the first time, which fulfills all of the methodological requirements for the analysis of clustered data, with the additional advantage of presenting the results to the biomedical community in a more familiar format. It also allows the representation of the pooled RR as a forest plot, in which the statistical significance of the result (95% confidence interval not crossing the reference line at RRϭ1), the contribution of each individual stent to the final result, and the heterogeneity of the effect can be easily and intuitively understood.
Limitations
We advise caution in regard to the use of OCT coverage as a surrogate for neointimal healing. Although biologically plausible and intuitively accepted by the scientific community, this approach cannot be fully supported by current evidence. OCT coverage correlates with histological neointimal healing and endothelialization after stenting in animal models, [33] [34] [35] but its sensitivity and specificity in human atherosclerotic vessels are still unknown. OCT is not able to detect thin Values are presented as count (%). DES indicates drug-eluting stents; ISA, incomplete stent apposition; and NASB, nonapposed side-branch struts. layers of endothelium below its 14-m axial resolution, eventually resulting in an overestimation of the incidence of delayed coverage, and it cannot discern between neointima and other material, like fibrin or thrombus. The analysis of optical density may be useful in the future to discern between neointima and thrombus/fibrin. 36 This analysis included OCT studies performed at different follow-up periods, ranging from 9 to 13 months. Although this is a potential limitation, it is not likely to significantly affect the results because in each case the follow-up was scheduled after healing was estimated to be complete, and no substantial variations were expected. Moreover, the statistical analysis compared the different apposition categories within the same stent, thus minimizing the impact of uneven follow-up periods in the results. Nonetheless, the level of evidence provided by data pooled from different trials may be lower than the level obtained by a homogeneous protocol of study in a randomized fashion. Despite strict inclusion and exclusion criteria for the OCT substudies, some selection bias of the patients most suitable for imaging cannot be completely ruled out.
Only OCT pullbacks at follow-up were analyzed, under the assumption that the apposition status of each strut remains stable along time. This assumption is acceptable for nonapposed side-branch struts but entails some selection bias for ISA struts. It has been described in OCT sequential studies that the proportion of ISA struts drops from baseline to follow-up because of partial integration in the neointima. The risk of noncoverage therefore may have been slightly overestimated in ISA. The choice for risk and RR in the pooled analysis is also based on this assumption, as well as because 
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mathematically it is a ratio of proportions, which fits better in the analysis performed. Although risk assessment would require the strict calculation of incidence between 2 time points, in OCT it is not possible to match individual struts between 2 different time points. With acknowledgment of its limitations, the assumption that apposition remains stable over time may be acceptable in some situations, and the complementary solution of sequential studies which assume in turn that struts can be tracked or their number does not change between 2 time points.
Conclusion
Coverage of ISA and nonapposed side-branch struts is delayed with respect to well-apposed struts in DES, as assessed by OCT.
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Supplemental material
Supplemental methods: Detailed explanation of the statistical analysis.
Pooled analysis is particularly suitable for the statistical analysis of an effect by combining data from different groups of subjects, each group submitted to slightly different environmental conditions. In this situation it is not acceptable to merge all the individuals together and apply conventional statistics, because one of the requirements for this approach is not accomplished: the individual measurements are not independent from each other, but strongly interdependent within the groups.
The biomedical community is actually very familiar with the methodology of pooled analysis, because it is used in:
· Meta-analysis 1 . · Epidemiology 2 .
In this study we propose for the first time to apply a pooled statistical method for the analysis of OCT data, since the clustering of data is an analogous methodological problem to the one faced by meta-analysis or by epidemiologic studies in communities. We can use pooled statistics in meta-analysis (combining different trials or studies), in interventional epidemiology (combining different communities) or in OCT studies (combining the results from different stents), (suppl. figure 1) .
Number of stents analyzed.
The number of stents analyzed depends on the research question, because not all the stents in the sample might be informative for all possible research questions.
In a meta-analysis we select the trials (or studies) addressing our research question, and then we select those which are truly informative to answer the question. To be informative a trial must have: · Exposition to the study factor · Events (at least in one of the arms). In a trial the exposition is guaranteed (randomization), but if we performed a meta-analysis of observational studies and we found studies with no exposition, they would be discarded (they are not informative for our research question).
Likewise, trials with no events (0 events in both arms) should be discarded (they are not informative for our research question).
In OCT studies, taking our manuscript as example (suppl. figure 2), these principles are applied as follows:
· Research question: compare the coverage of NASB vs. WA struts.
o Stents with no exposition (no NASB struts) are discarded. o In this case we need exposition (ISA) and no exposition (NASB) together in the same stent: therefore stents not meeting this condition are discarded. o Stents with no events (complete coverage of ISA and NASB struts) are discarded.
Supplemental figure legends:
Suppl. figure 1: Scheme illustrating the parallelism between the units of measurement and units of clustering in different types of studies using pooled analysis. Meta-analysis and epidemiology use pooled analysis, with patients clustered in trials, or individuals clustered in communities, respectively. This justifies the use of this methodology in some OCT studies, considering the struts the unit of measurement and the stent (or the lesion) as unit of clustering.
Suppl. figure 2:
Diagram illustrating the parallelism between the terminology used in meta-analysis and how to apply it in pooled analysis for this specific OCT study. Uncovered struts are equivalent to the events in meta-analysis, and the treatment vs. control (or exposed vs. non-exposed) categories depend on the research question that we intend to answer, i.e. for calculating the risk of delayed coverage in NASB vs. WA struts, NASB will be the treatment (or exposition) category, whilst WA will be the control (or non-exposed category).
ISA: Incomplete stent apposition; NASB: Non-apposed side-branch struts; WA: Wellapposed struts.
